Cargando…
EBUS versus EUS‐B for diagnosing sarcoidosis: The International Sarcoidosis Assessment (ISA) randomized clinical trial
BACKGROUND AND OBJECTIVE: Endosonography with intrathoracic nodal sampling is proposed as the single test with the highest granuloma detection rate in suspected sarcoidosis stage I/II. However, most studies have been performed in limited geographical regions. Studies suggest that oesophageal endoson...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299594/ https://www.ncbi.nlm.nih.gov/pubmed/34792268 http://dx.doi.org/10.1111/resp.14182 |
_version_ | 1784751009472446464 |
---|---|
author | Crombag, Laurence M. M. Mooij‐Kalverda, Kirsten Szlubowski, Artur Gnass, Maciej Tournoy, Kurt G. Sun, Jiayuan Oki, Masahide Ninaber, Maarten K. Steinfort, Daniel P. Jennings, Barton R. Liberman, Moishe Bilaceroglu, Semra Bonta, Peter I. Korevaar, Daniël A. Trisolini, Rocco Annema, Jouke T. |
author_facet | Crombag, Laurence M. M. Mooij‐Kalverda, Kirsten Szlubowski, Artur Gnass, Maciej Tournoy, Kurt G. Sun, Jiayuan Oki, Masahide Ninaber, Maarten K. Steinfort, Daniel P. Jennings, Barton R. Liberman, Moishe Bilaceroglu, Semra Bonta, Peter I. Korevaar, Daniël A. Trisolini, Rocco Annema, Jouke T. |
author_sort | Crombag, Laurence M. M. |
collection | PubMed |
description | BACKGROUND AND OBJECTIVE: Endosonography with intrathoracic nodal sampling is proposed as the single test with the highest granuloma detection rate in suspected sarcoidosis stage I/II. However, most studies have been performed in limited geographical regions. Studies suggest that oesophageal endosonographic nodal sampling has higher diagnostic yield than endobronchial endosonographic nodal sampling, but a head‐to‐head comparison of both routes has never been performed. METHODS: Global (14 hospitals, nine countries, four continents) randomized clinical trial was conducted in consecutive patients with suspected sarcoidosis stage I/II presenting between May 2015 and August 2017. Using an endobronchial ultrasound (EBUS) scope, patients were randomized to EBUS or endoscopic ultrasound (EUS)‐B‐guided nodal sampling, and to 22‐ or 25‐G ProCore needle aspiration (2 × 2 factorial design). Granuloma detection rate was the primary study endpoint. Final diagnosis was based on cytology/pathology outcomes and clinical/radiological follow‐up at 6 months. RESULTS: A total of 358 patients were randomized: 185 patients to EBUS‐transbronchial needle aspiration (EBUS‐TBNA) and 173 to EUS‐B‐fine‐needle aspiration (FNA). Final diagnosis was sarcoidosis in 306 patients (86%). Granuloma detection rate was 70% (130/185; 95% CI, 63–76) for EBUS‐TBNA and 68% (118/173; 95% CI, 61–75) for EUS‐B‐FNA (p = 0.67). Sensitivity for diagnosing sarcoidosis was 78% (129/165; 95% CI, 71–84) for EBUS‐TBNA and 82% (115/141; 95% CI, 74–87) for EUS‐B‐FNA (p = 0.46). There was no significant difference between the two needle types in granuloma detection rate or sensitivity. CONCLUSION: Granuloma detection rate of mediastinal/hilar nodes by endosonography in patients with suspected sarcoidosis stage I/II is high and similar for EBUS and EUS‐B. These findings imply that both diagnostic tests can be safely and universally used in suspected sarcoidosis patients. |
format | Online Article Text |
id | pubmed-9299594 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley & Sons, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-92995942022-07-21 EBUS versus EUS‐B for diagnosing sarcoidosis: The International Sarcoidosis Assessment (ISA) randomized clinical trial Crombag, Laurence M. M. Mooij‐Kalverda, Kirsten Szlubowski, Artur Gnass, Maciej Tournoy, Kurt G. Sun, Jiayuan Oki, Masahide Ninaber, Maarten K. Steinfort, Daniel P. Jennings, Barton R. Liberman, Moishe Bilaceroglu, Semra Bonta, Peter I. Korevaar, Daniël A. Trisolini, Rocco Annema, Jouke T. Respirology ORIGINAL ARTICLES BACKGROUND AND OBJECTIVE: Endosonography with intrathoracic nodal sampling is proposed as the single test with the highest granuloma detection rate in suspected sarcoidosis stage I/II. However, most studies have been performed in limited geographical regions. Studies suggest that oesophageal endosonographic nodal sampling has higher diagnostic yield than endobronchial endosonographic nodal sampling, but a head‐to‐head comparison of both routes has never been performed. METHODS: Global (14 hospitals, nine countries, four continents) randomized clinical trial was conducted in consecutive patients with suspected sarcoidosis stage I/II presenting between May 2015 and August 2017. Using an endobronchial ultrasound (EBUS) scope, patients were randomized to EBUS or endoscopic ultrasound (EUS)‐B‐guided nodal sampling, and to 22‐ or 25‐G ProCore needle aspiration (2 × 2 factorial design). Granuloma detection rate was the primary study endpoint. Final diagnosis was based on cytology/pathology outcomes and clinical/radiological follow‐up at 6 months. RESULTS: A total of 358 patients were randomized: 185 patients to EBUS‐transbronchial needle aspiration (EBUS‐TBNA) and 173 to EUS‐B‐fine‐needle aspiration (FNA). Final diagnosis was sarcoidosis in 306 patients (86%). Granuloma detection rate was 70% (130/185; 95% CI, 63–76) for EBUS‐TBNA and 68% (118/173; 95% CI, 61–75) for EUS‐B‐FNA (p = 0.67). Sensitivity for diagnosing sarcoidosis was 78% (129/165; 95% CI, 71–84) for EBUS‐TBNA and 82% (115/141; 95% CI, 74–87) for EUS‐B‐FNA (p = 0.46). There was no significant difference between the two needle types in granuloma detection rate or sensitivity. CONCLUSION: Granuloma detection rate of mediastinal/hilar nodes by endosonography in patients with suspected sarcoidosis stage I/II is high and similar for EBUS and EUS‐B. These findings imply that both diagnostic tests can be safely and universally used in suspected sarcoidosis patients. John Wiley & Sons, Ltd 2021-11-17 2022-02 /pmc/articles/PMC9299594/ /pubmed/34792268 http://dx.doi.org/10.1111/resp.14182 Text en © 2021 The Authors. Respirology published by John Wiley & Sons Australia, Ltd on behalf of Asian Pacific Society of Respirology. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | ORIGINAL ARTICLES Crombag, Laurence M. M. Mooij‐Kalverda, Kirsten Szlubowski, Artur Gnass, Maciej Tournoy, Kurt G. Sun, Jiayuan Oki, Masahide Ninaber, Maarten K. Steinfort, Daniel P. Jennings, Barton R. Liberman, Moishe Bilaceroglu, Semra Bonta, Peter I. Korevaar, Daniël A. Trisolini, Rocco Annema, Jouke T. EBUS versus EUS‐B for diagnosing sarcoidosis: The International Sarcoidosis Assessment (ISA) randomized clinical trial |
title |
EBUS versus EUS‐B for diagnosing sarcoidosis: The International Sarcoidosis Assessment (ISA) randomized clinical trial |
title_full |
EBUS versus EUS‐B for diagnosing sarcoidosis: The International Sarcoidosis Assessment (ISA) randomized clinical trial |
title_fullStr |
EBUS versus EUS‐B for diagnosing sarcoidosis: The International Sarcoidosis Assessment (ISA) randomized clinical trial |
title_full_unstemmed |
EBUS versus EUS‐B for diagnosing sarcoidosis: The International Sarcoidosis Assessment (ISA) randomized clinical trial |
title_short |
EBUS versus EUS‐B for diagnosing sarcoidosis: The International Sarcoidosis Assessment (ISA) randomized clinical trial |
title_sort | ebus versus eus‐b for diagnosing sarcoidosis: the international sarcoidosis assessment (isa) randomized clinical trial |
topic | ORIGINAL ARTICLES |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299594/ https://www.ncbi.nlm.nih.gov/pubmed/34792268 http://dx.doi.org/10.1111/resp.14182 |
work_keys_str_mv | AT crombaglaurencemm ebusversuseusbfordiagnosingsarcoidosistheinternationalsarcoidosisassessmentisarandomizedclinicaltrial AT mooijkalverdakirsten ebusversuseusbfordiagnosingsarcoidosistheinternationalsarcoidosisassessmentisarandomizedclinicaltrial AT szlubowskiartur ebusversuseusbfordiagnosingsarcoidosistheinternationalsarcoidosisassessmentisarandomizedclinicaltrial AT gnassmaciej ebusversuseusbfordiagnosingsarcoidosistheinternationalsarcoidosisassessmentisarandomizedclinicaltrial AT tournoykurtg ebusversuseusbfordiagnosingsarcoidosistheinternationalsarcoidosisassessmentisarandomizedclinicaltrial AT sunjiayuan ebusversuseusbfordiagnosingsarcoidosistheinternationalsarcoidosisassessmentisarandomizedclinicaltrial AT okimasahide ebusversuseusbfordiagnosingsarcoidosistheinternationalsarcoidosisassessmentisarandomizedclinicaltrial AT ninabermaartenk ebusversuseusbfordiagnosingsarcoidosistheinternationalsarcoidosisassessmentisarandomizedclinicaltrial AT steinfortdanielp ebusversuseusbfordiagnosingsarcoidosistheinternationalsarcoidosisassessmentisarandomizedclinicaltrial AT jenningsbartonr ebusversuseusbfordiagnosingsarcoidosistheinternationalsarcoidosisassessmentisarandomizedclinicaltrial AT libermanmoishe ebusversuseusbfordiagnosingsarcoidosistheinternationalsarcoidosisassessmentisarandomizedclinicaltrial AT bilaceroglusemra ebusversuseusbfordiagnosingsarcoidosistheinternationalsarcoidosisassessmentisarandomizedclinicaltrial AT bontapeteri ebusversuseusbfordiagnosingsarcoidosistheinternationalsarcoidosisassessmentisarandomizedclinicaltrial AT korevaardaniela ebusversuseusbfordiagnosingsarcoidosistheinternationalsarcoidosisassessmentisarandomizedclinicaltrial AT trisolinirocco ebusversuseusbfordiagnosingsarcoidosistheinternationalsarcoidosisassessmentisarandomizedclinicaltrial AT annemajouket ebusversuseusbfordiagnosingsarcoidosistheinternationalsarcoidosisassessmentisarandomizedclinicaltrial |